Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus

Abstract Background Toxoplasmosis is probably one of the most common parasitic infections of humans. While infection of healthy adults is usually relatively mild, serious disease can result in utero or when the host is immuno-compromised. Toxoplasmosis in diabetic patients may occur due to recently...

Full description

Bibliographic Details
Main Authors: Hala M. Khattab, Safeya O. El Bassiouni, Manal H. Abuelela, Dalia O. Abd Elsalam
Format: Article
Language:English
Published: SpringerOpen 2019-02-01
Series:Bulletin of the National Research Centre
Subjects:
Online Access:http://link.springer.com/article/10.1186/s42269-019-0059-0
_version_ 1818020999127367680
author Hala M. Khattab
Safeya O. El Bassiouni
Manal H. Abuelela
Dalia O. Abd Elsalam
author_facet Hala M. Khattab
Safeya O. El Bassiouni
Manal H. Abuelela
Dalia O. Abd Elsalam
author_sort Hala M. Khattab
collection DOAJ
description Abstract Background Toxoplasmosis is probably one of the most common parasitic infections of humans. While infection of healthy adults is usually relatively mild, serious disease can result in utero or when the host is immuno-compromised. Toxoplasmosis in diabetic patients may occur due to recently acquired acute infection or they may suffer from dissemination of reactivated latent infection. In the present study, the antinuclear antibody prevalence was tested to determine the possible relationship with Toxoplasma seroprevalence and clinical findings in type I diabetic patients. Methods Toxoplasma gondii antibodies were tested serologically in 60 patients of type I diabetes mellitus and 60 controls using ELISA technique. Results The seropositivity for anti-Toxoplasma IgG antibodies in the study groups was 45% in type I diabetes mellitus patients (group 1) and 23.3% in the control (group 2) with p value = 0.012 showing a statistically significant difference between groups, while only three patients of diabetes type1 group were positive for anti-Toxoplasma IgM with p value = 0.244 showing no statistically significant differences between the two groups. Results showed that only one patient of diabetes type 1 (group1) had positive ANA and one control (group2) had positive ANA. Thus, no correlation could be detected from such results. Conclusion The study results showed a statistically significantly higher proportion (45%) of seropositivity anti-Toxoplasma IgG antibodies among type I diabetes mellitus patients compared to 23.3% among the control group, while there was no association could be detected between the studied groups regarding the ANA.
first_indexed 2024-04-14T08:13:07Z
format Article
id doaj.art-a9abf608260f445494a8321c626d81b3
institution Directory Open Access Journal
issn 2522-8307
language English
last_indexed 2024-04-14T08:13:07Z
publishDate 2019-02-01
publisher SpringerOpen
record_format Article
series Bulletin of the National Research Centre
spelling doaj.art-a9abf608260f445494a8321c626d81b32022-12-22T02:04:29ZengSpringerOpenBulletin of the National Research Centre2522-83072019-02-014311710.1186/s42269-019-0059-0Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitusHala M. Khattab0Safeya O. El Bassiouni1Manal H. Abuelela2Dalia O. Abd Elsalam3Medical Parasitology Department, Research Institute of OphthalmologyMedical Parasitology Department, Faculty of Medicine, Cairo UniversityPublic Health Department, Research Institute of OphthalmologyMedical Parasitology Department, Research Institute of OphthalmologyAbstract Background Toxoplasmosis is probably one of the most common parasitic infections of humans. While infection of healthy adults is usually relatively mild, serious disease can result in utero or when the host is immuno-compromised. Toxoplasmosis in diabetic patients may occur due to recently acquired acute infection or they may suffer from dissemination of reactivated latent infection. In the present study, the antinuclear antibody prevalence was tested to determine the possible relationship with Toxoplasma seroprevalence and clinical findings in type I diabetic patients. Methods Toxoplasma gondii antibodies were tested serologically in 60 patients of type I diabetes mellitus and 60 controls using ELISA technique. Results The seropositivity for anti-Toxoplasma IgG antibodies in the study groups was 45% in type I diabetes mellitus patients (group 1) and 23.3% in the control (group 2) with p value = 0.012 showing a statistically significant difference between groups, while only three patients of diabetes type1 group were positive for anti-Toxoplasma IgM with p value = 0.244 showing no statistically significant differences between the two groups. Results showed that only one patient of diabetes type 1 (group1) had positive ANA and one control (group2) had positive ANA. Thus, no correlation could be detected from such results. Conclusion The study results showed a statistically significantly higher proportion (45%) of seropositivity anti-Toxoplasma IgG antibodies among type I diabetes mellitus patients compared to 23.3% among the control group, while there was no association could be detected between the studied groups regarding the ANA.http://link.springer.com/article/10.1186/s42269-019-0059-0Toxoplasma gondiiDiabetes mellitusANAELISAIgG and IgM antibodies
spellingShingle Hala M. Khattab
Safeya O. El Bassiouni
Manal H. Abuelela
Dalia O. Abd Elsalam
Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus
Bulletin of the National Research Centre
Toxoplasma gondii
Diabetes mellitus
ANA
ELISA
IgG and IgM antibodies
title Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus
title_full Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus
title_fullStr Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus
title_full_unstemmed Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus
title_short Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus
title_sort seroprevalence of toxoplasma gondii among a group of egyptian patients with type i diabetes mellitus
topic Toxoplasma gondii
Diabetes mellitus
ANA
ELISA
IgG and IgM antibodies
url http://link.springer.com/article/10.1186/s42269-019-0059-0
work_keys_str_mv AT halamkhattab seroprevalenceoftoxoplasmagondiiamongagroupofegyptianpatientswithtypeidiabetesmellitus
AT safeyaoelbassiouni seroprevalenceoftoxoplasmagondiiamongagroupofegyptianpatientswithtypeidiabetesmellitus
AT manalhabuelela seroprevalenceoftoxoplasmagondiiamongagroupofegyptianpatientswithtypeidiabetesmellitus
AT daliaoabdelsalam seroprevalenceoftoxoplasmagondiiamongagroupofegyptianpatientswithtypeidiabetesmellitus